Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Cytoreductive nephrectomy for RCC

Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, discusses his analysis of cytoreductive nephrectomy for metastatic renal cell carcinoma (RCC) treated with immune checkpoint inhibitors or targeted therapy. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.